Human serum components

Human serum components refer to the complex mixture of proteins, electrolytes, hormones, and metabolites found in the liquid portion of blood after coagulation has occurred [4]. While not a single therapeutic target, these components—most notably human serum albumin (HSA) and alpha-1-acid glycoprotein (AGP)—play a critical role in pharmacology by binding and transporting a wide array of endogenous and exogenous compounds [1][2]. The degree of drug binding to these components significantly influences a drug's volume of distribution, half-life, and the free fraction available for therapeutic action [3]. Alterations in the concentration or composition of serum components due to disease states like cirrhosis or nephrotic syndrome can lead to unpredictable drug responses and toxicity [1]. Consequently, understanding the interaction between drugs and serum components is essential for pharmacokinetic modeling and clinical dosing strategies [3]. This collective entity is often used in assays to determine the protein-binding affinity of new chemical entities during drug development [2].

Other names

Serum proteinsBlood serumSerum matrixCirculating serum components

Drugs interact with human serum components primarily through reversible non-specific binding to proteins like albumin and alpha-1-acid glycoprotein [1][3]. This binding serves to transport the drug and regulate its free concentration in the blood, which is the fraction available to exert a pharmacological effect [3].